Patent ID: 9011907
Filing Date: 2015-04-21
Classification: A61K,A61P

Abstract:
1. A pharmaceutical or nutraceutical preparation having a sigmoidal release profile which releases more than 90% of its pharmaceutically or nutraceutically active components within 10 hours of oral administration, consisting essentially of: a) a core comprising a pharmaceutically or nutraceutically active substance and a substance that acts in a modulatory manner, during release of the pharmaceutically or nutraceutically active substance; and b) a single controlling layer surrounding the core comprising i) 55 to 92% by weight, based on a total weight of (meth)acrylic acid ester copolymers present in the layer, of first (meth)acrylic acid ester copolymers; and ii) 8 to 45% by weight, based on the total weight of (meth)acrylic acid ester copolymers present in the layer, of second (meth)acrylic acid ester copolymers;